Zantac / Ranitidine (NDMA Cancer) Lawsuit in New Jersey

Preparing your case review…
Written By
People's Justice Legal Research Team

Statute of Limitations

New Jersey has a 2-year statute of limitations for personal injury claims (N.J.S.A. 2A:14-2) with the discovery rule applicable. New Jersey courts apply a Daubert-based reliability standard for expert testimony under N.J.R.E. 702, similar to federal court. New Jersey is home to major pharmaceutical manufacturers and has historically served as a pharmaceutical mass tort venue (Vioxx litigation, NPC litigation). Sanofi has significant New Jersey operations, creating strong jurisdictional contacts.

2 years from date of cancer diagnosis discovery (Daubert-based expert standard)

New Jersey Data

Exposure in New Jersey

Source: U.S. Census Bureau 2024

Source: New Jersey State Cancer Registry 2024

Source: New Jersey pharmaceutical industry demographics

Medical Resources

Clinics & Specialists in New Jersey

Rutgers Cancer Institute of New Jersey

Memorial Sloan Kettering — Basking Ridge

FAQ

Frequently Asked Questions

See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
Back to Zantac / Ranitidine (NDMA Cancer) Lawsuit Overview